These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The innate immune response against Brucella in humans. Dornand J; Gross A; Lafont V; Liautard J; Oliaro J; Liautard JP Vet Microbiol; 2002 Dec; 90(1-4):383-94. PubMed ID: 12414158 [TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity in human brucellosis. Skendros P; Pappas G; Boura P Microbes Infect; 2011 Feb; 13(2):134-42. PubMed ID: 21034846 [TBL] [Abstract][Full Text] [Related]
4. Establishment of Chronic Infection: Brucella's Stealth Strategy. Ahmed W; Zheng K; Liu ZF Front Cell Infect Microbiol; 2016; 6():30. PubMed ID: 27014640 [TBL] [Abstract][Full Text] [Related]
5. Antigen-specific activation and proliferation of CD4+ and CD8+ T lymphocytes from brucellosis patients. Moreno-Lafont MC; López-Santiago R; Zumarán-Cuéllar E; Paredes-Cervantes V; López-Merino A; Estrada-Aguilera A; Santos-Argumedo L Trans R Soc Trop Med Hyg; 2002; 96(3):340-7. PubMed ID: 12174793 [TBL] [Abstract][Full Text] [Related]
6. [Evasion of anti-infectious immunity by Brucella - A review]. Quan W; Yang Y Wei Sheng Wu Xue Bao; 2016 May; 56(5):747-52. PubMed ID: 29727136 [TBL] [Abstract][Full Text] [Related]
8. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. Barquero-Calvo E; Chaves-Olarte E; Weiss DS; Guzmán-Verri C; Chacón-Díaz C; Rucavado A; Moriyón I; Moreno E PLoS One; 2007 Jul; 2(7):e631. PubMed ID: 17637846 [TBL] [Abstract][Full Text] [Related]
9. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model. Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688 [TBL] [Abstract][Full Text] [Related]
10. Active evasion of CTL mediated killing and low quality responding CD8+ T cells contribute to persistence of brucellosis. Durward M; Radhakrishnan G; Harms J; Bareiss C; Magnani D; Splitter GA PLoS One; 2012; 7(4):e34925. PubMed ID: 22558103 [TBL] [Abstract][Full Text] [Related]
11. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ. Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204 [TBL] [Abstract][Full Text] [Related]
12. Reduced IFN-γ Production in Chronic Brucellosis Patients. Ghaznavi Rad E; Khosravi K; Zarinfar N; Mosayebi G Iran J Immunol; 2017 Sep; 14(3):215-222. PubMed ID: 28919584 [TBL] [Abstract][Full Text] [Related]
13. Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. Giambartolomei GH; Delpino MV; Cahanovich ME; Wallach JC; Baldi PC; Velikovsky CA; Fossati CA J Infect Dis; 2002 Jul; 186(2):252-9. PubMed ID: 12134263 [TBL] [Abstract][Full Text] [Related]
14. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen. Machelart A; Khadrawi A; Demars A; Willemart K; De Trez C; Letesson JJ; Muraille E Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808159 [TBL] [Abstract][Full Text] [Related]
15. Neutrophils exert a suppressive effect on Th1 responses to intracellular pathogen Brucella abortus. Barquero-Calvo E; Martirosyan A; Ordoñez-Rueda D; Arce-Gorvel V; Alfaro-Alarcón A; Lepidi H; Malissen B; Malissen M; Gorvel JP; Moreno E PLoS Pathog; 2013 Feb; 9(2):e1003167. PubMed ID: 23458832 [TBL] [Abstract][Full Text] [Related]
16. Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis. Vitry MA; Hanot Mambres D; De Trez C; Akira S; Ryffel B; Letesson JJ; Muraille E J Immunol; 2014 Apr; 192(8):3740-52. PubMed ID: 24646742 [TBL] [Abstract][Full Text] [Related]
17. Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria. Bessoles S; Ni M; Garcia-Jimenez S; Sanchez F; Lafont V Eur J Immunol; 2011 Jun; 41(6):1619-28. PubMed ID: 21469127 [TBL] [Abstract][Full Text] [Related]
18. An evolutionary strategy for a stealthy intracellular Brucella pathogen. Martirosyan A; Moreno E; Gorvel JP Immunol Rev; 2011 Mar; 240(1):211-34. PubMed ID: 21349096 [TBL] [Abstract][Full Text] [Related]